hameln pharma ApS — Credit Rating and Financial Key Figures
CVR number: 39720213
Naverland 22, 2600 Glostrup
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 403.94 | 1 874.15 | 2 613.04 | 3 130.28 | 6 856.81 |
| Total depreciation | -13.33 | ||||
| EBIT | 2 390.61 | 1 874.15 | 2 613.04 | 3 130.28 | 6 856.81 |
| Other financial income | 2.98 | 13.62 | 142.04 | ||
| Other financial expenses | -19.96 | -49.98 | - 161.69 | - 161.10 | - 140.25 |
| Pre-tax profit | 2 370.64 | 1 824.17 | 2 454.33 | 2 982.79 | 6 858.60 |
| Income taxes | - 506.88 | - 407.59 | - 544.22 | - 658.24 | -1 569.93 |
| Net earnings | 1 863.76 | 1 416.58 | 1 910.11 | 2 324.55 | 5 288.67 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 1 682.04 | 3 164.33 | 3 525.70 | 6 093.64 | 6 326.49 |
| Inventories total | 1 682.04 | 3 164.33 | 3 525.70 | 6 093.64 | 6 326.49 |
| Current trade debtors | 856.96 | 1 219.05 | 2 822.24 | 6 969.36 | 4 755.67 |
| Current amounts owed by group member comp. | 41.20 | ||||
| Prepayments and accrued income | 104.49 | 107.84 | 133.49 | 149.73 | 149.84 |
| Current other receivables | 9.43 | 408.84 | 408.40 | ||
| Current deferred tax assets | 49.41 | 225.78 | |||
| Short term receivables total | 961.45 | 1 376.29 | 3 190.93 | 7 527.93 | 5 355.10 |
| Cash and bank deposits | 3 316.67 | 666.86 | 2 718.63 | 1 912.68 | 6 946.86 |
| Cash and cash equivalents | 3 316.67 | 666.86 | 2 718.63 | 1 912.68 | 6 946.86 |
| Balance sheet total (assets) | 5 960.15 | 5 207.49 | 9 435.26 | 15 534.25 | 18 628.46 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -82.73 | 1 781.03 | 3 083.85 | 5 001.96 | 6 958.53 |
| Profit of the financial year | 1 863.76 | 1 416.58 | 1 910.11 | 2 324.55 | 5 288.67 |
| Shareholders equity total | 1 831.03 | 3 247.61 | 5 043.96 | 7 376.51 | 12 297.20 |
| Non-current owed to group member | 2 678.33 | ||||
| Non-current liabilities total | 2 678.33 | ||||
| Current trade creditors | 208.81 | 292.10 | 1 354.25 | 2 912.89 | 712.92 |
| Current owed to group member | 1 433.76 | 2 417.08 | 3 124.59 | 3 130.48 | |
| Short-term deferred tax liabilities | 506.88 | 902.75 | 935.83 | ||
| Other non-interest bearing current liabilities | 735.10 | 234.02 | 619.96 | 1 217.51 | 1 552.03 |
| Current liabilities total | 1 450.79 | 1 959.88 | 4 391.30 | 8 157.74 | 6 331.25 |
| Balance sheet total (liabilities) | 5 960.15 | 5 207.49 | 9 435.26 | 15 534.25 | 18 628.46 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.